Home Cart Sign in  
Chemical Structure| 849214-04-6 Chemical Structure| 849214-04-6

Structure of cGAMP
CAS No.: 849214-04-6

Chemical Structure| 849214-04-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

cGAMP, an endogenous second messenger, can induce the formation of cytokines and promote innate immune response. It also acts as an activator of STING with antitumor activity.

Synonyms: Cyclic GMP-AMP; 3',3'-cGAMP

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of cGAMP

CAS No. :849214-04-6
Formula : C20H24N10O13P2
M.W : 674.41
SMILES Code : O=P(O[C@H]1[C@@H](O)[C@H](N2C=NC3=C2N=CN=C3N)O[C@@H]1COP4(O)=O)(O)OC[C@@H]5[C@@H](O4)[C@@H](O)[C@H](N6C=NC7=C6N=C(N)NC7=O)O5
Synonyms :
Cyclic GMP-AMP; 3',3'-cGAMP
MDL No. :N/A
InChI Key :RFCBNSCSPXMEBK-INFSMZHSSA-N
Pubchem ID :135471108

Safety of cGAMP

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 1 μM 1 h To evaluate the effect of cGAMP on phosphorylation of STING, TBK1, and IRF3 Nature. 2022 Apr;604(7906):557-562
mouse splenic B cells 5μg/mL 24 h To investigate the effect of cGAMP on IL-35 and IL-10 expression in B cells, results showed that cGAMP significantly increased the frequency of IL-35 and IL-10 in WT but not in Tmem173−/− B cells. Nature. 2022 Oct;610(7931):373-380
THP-1 cells 100 μM 24 h Evaluate the role of P2RX7 in cGAMP-induced STING activation J Neuroinflammation. 2025 Mar 1;22(1):58
Primary human macrophages 100 μM 24 h Evaluate the role of P2RX7 in cGAMP-induced STING activation J Neuroinflammation. 2025 Mar 1;22(1):58
Bone marrow-derived dendritic cells (BMDCs) 1 μg/mL 24 and 48 h To evaluate the ability of cGAMP as a STING agonist to induce IFN-β secretion in BMDCs. Results showed that cGAMP encapsulated in Ace-DEX MPs induced higher IFN-β secretion compared to soluble or lipofectamine-complexed cGAMP. Int J Pharm. 2022 Jun 25;622:121839
bone marrow-derived macrophage (BMDMs) 100 nM 4 h To evaluate the activation of STING pathway and type I IFN production by NP-cGAMP. NP-cGAMP induced a drastic increase in expression of Ifnb1 and Ifna1, as well as other proinflammatory genes. Nat Commun. 2019 Nov 8;10(1):5108
bone marrow-derived dendritic cells (BMDCs) 100 nM 4 h To evaluate the activation of STING pathway and type I IFN production by NP-cGAMP. NP-cGAMP induced a drastic increase in expression of Ifnb1 and Ifna1, as well as other proinflammatory genes. Nat Commun. 2019 Nov 8;10(1):5108
alveolar macrophage (AM) 100 nM 4 h To evaluate the activation of STING pathway and type I IFN production by NP-cGAMP. NP-cGAMP induced a drastic increase in expression of Ifnb1 and Ifna1, as well as other proinflammatory genes. Nat Commun. 2019 Nov 8;10(1):5108

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Immunization model Footpad injection 5 μg,20 μL Single or multiple immunizations CGAMP enhances the differentiation of germinal center B cells (BGC) and plasma cells (BPC), and increases antigen-specific antibody production. Front Immunol. 2024 Apr 12;15:1340001
DBA/2 J mice Influenza viral challenge model Intramuscular injection 1 µg/mouse Vaccinated at weeks 0, 3, and 6, totaling 3 doses Evaluated the protective immune responses of cGAMP MPs adjuvanted COBRA HA vaccines in mice, showing mitigation of disease symptoms and reduced pulmonary viral titers mSphere. 2024 Jul 30;9(7):e0016024
Mice STING mutant mice (S365A, L373A, ΔCTT) Intratumoral injection 10 μg Administered on days 5, 8, 11, and 14 after tumor implantation To study the antitumor effect of cGAMP in STING mutant mice. Results showed that STING-S365A mice retained the antitumor response, while L373A and ΔCTT mice lost this effect. Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):e2100225118
Mice Implanted LLC tumor model, MMTV-PyMT spontaneous breast cancer model Intratumoral injection 14 μg, 70 μl Single injection, sampled 24 hours later Evaluate the effect of cGAMP on tumor vascular disruption and anti-tumor growth, results showed cGAMP significantly induced tumor endothelial cell apoptosis and suppressed tumor growth Nat Commun. 2021 Jul 20;12(1):4405
C57BL/6J mice Influenza vaccine immunization model Intramuscular injection 1 μg According to the immunization schedule in Figure 4A To evaluate the immunogenicity of cGAMP as an adjuvant in COBRA HA vaccine. Results showed that cGAMP MP-adjuvanted groups induced higher anti-Y2 IgG antibody titers than the unadjuvanted group, and compared to Addavax, cGAMP MPs induced a stronger Th1-skewed immune response (IgG2C). Int J Pharm. 2022 Jun 25;622:121839
Mice Pancreatic ductal adenocarcinoma (PDAC) model Intravenous injection 10μg/mL Every three days for a total of 4 times To evaluate the effect of cGAMP on tumor growth and immune cell infiltration, results showed that cGAMP increased the percent of CD19+ B cells among the CD45+ cells and the absolute number of B cells in the tumours by day 21 but had no effect on tumour growth. Nature. 2022 Oct;610(7931):373-380

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.48mL

0.30mL

0.15mL

7.41mL

1.48mL

0.74mL

14.83mL

2.97mL

1.48mL

References

[1]Wu J, Sun L, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013 Feb 15;339(6121):826-30.

[2]Ablasser A, Schmid-Burgk JL, et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature. 2013 Nov 28;503(7477):530-4.

[3]Liu Y, Jesus AA, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014 Aug 7;371(6):507-518.

[4]Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013 Feb 15;339(6121):826-30. doi: 10.1126/science.1229963. Epub 2012 Dec 20. PMID: 23258412; PMCID: PMC3855410.

[5]Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, Hornung V. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature. 2013 Nov 28;503(7477):530-4. doi: 10.1038/nature12640. Epub 2013 Sep 29. PMID: 24077100; PMCID: PMC4142317.

[6]Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, Lee CR, DiMattia MA, Cowen EW, Gonzalez B, Palmer I, DiGiovanna JJ, Biancotto A, Kim H, Tsai WL, Trier AM, Huang Y, Stone DL, Hill S, Kim HJ, St Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland SM, Hughes JD, Mehmet H, Issekutz AC, Raffeld M, McElwee J, Fontana JR, Minniti CP, Moir S, Kastner DL, Gadina M, Steven AC, Wingfield PT, Brooks SR, Rosenzweig SD, Fleisher TA, Deng Z, Boehm M, Paller AS, Goldbach-Mansky R. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014 Aug 7;371(6):507-518. doi: 10.1056/NEJMoa1312625. Epub 2014 Jul 16. PMID: 25029335; PMCID: PMC4174543.

 

Historical Records

Categories